ADVERTISEMENT
 |
|
Top BioPharm International News Stories of 2018
|
|
|
The company has run into a snag in producing Kymriah for the diffuse large B-cell lymphoma patient population, the second indication for which the therapy was recently approved by FDA.
/ read more /
Celltrion received complete response letters from FDA for its rituximab and trastuzumab biosimilars.
/ read more /
The pharma major will spin out six molecules in early stage inflammation and autoimmune programs into a new company called Viela Bio.
/ read more /
The acquisition would boost Sanofi's position in hematology and specialty medicines.
/ read more /
The biopharmaceutical firm has chosen Rhode Island as the site of its next-generation biomanufacturing plant, which will offer flexibility, speed, and efficiency.
/ read more /
The acquisition is expected to accelerate progress towards personalized cancer healthcare.
/ read more /
|
|
SubscribeSubscribers can enjoy each full issue of BioPharm International in print, or via BioPharm apps.
subscription offers
|
|
|
|
Stem-cell developer TiGenix has been acquired by Takeda Pharmaceutical for approximately EUR 520 million (US$604 million).
/ read more /
The new drug, Onpattro (patisiran), by Alnylam Pharmaceuticals, is in a new class of drugs called small interfering ribonucleic acid (siRNA) treatment.
/ read more /
President Donald Trump announced his strategy for making prescription medicines more affordable and accessible in the United States.
/ read more /
The gene therapy company is expected to invest $55 million in a new manufacturing facility that will produce therapies for rare neurological genetic diseases.
/ read more /
|
|
|
Top BioPharm International Feature Stories of 2018
|
|
|
The authors present a robust and easy-to-implement chromatography column performance assessment method, called direct transition analysis (DTA).
/ read more /
Single-use technologies are starting to gain ground as capacity needs change, but industrywide adoption remains low.
/ read more /
Advances in TFF and single-use systems help advance UF/DF on the continuous processing path.
/ read more /
Experts share insights on the various methods used for purity and impurity analysis of therapeutic proteins.
/ read more /
More consistent and reliable production processes are critical for advancing innovative treatments.
/ read more /
|
|
|
|
Early adopters are benefiting from lower costs and increased productivity.
/ read more /
Advances in wearable devices have made it possible to deliver high-volume, high-viscosity biologics.
/ read more /
Process understanding and careful assessment of risks are essential in developing viral clearance programs.
/ read more /
Statistical methods to identify critical process parameters and critical material attributes–and approaches to control them–are needed to protect drug product and drug substances.
/ read more /
Conducting stability testing on APIs/finished drug product helps ensure shelf-life storage.
/ read more /
|
|
|
Events
January 21–23, 2019
February 6–7, 2019
March 3–6, 2019
more events
|
|
|
eBook
|
This eBook covers method development, analytical techniques, and profiles of new instruments, equipment, and supplies used in the testing and analysis of raw materials, drug substances, and drug products.
|
|
|
|
|
